Today's Top 20 Gastroenterology and Endoscopy Stories
-
More gastroenterologists needed in cystic fibrosis care: Study
A recent survey published in Nutrition in Clinical Practice found the involvement of gastroenterologists in caring for cystic fibrosis patients varied widely across specialty centers, Cystic Fibrosis News Today reported Oct. 10. -
Oregon specialists warn public about CRC blood-test
In July, the FDA approved a new screening test for colorectal cancer that only requires a sample of blood. -
Gastroenterology under pressure amid mounting challenges
From pay declines to rising procedure demand, gastroenterology leaders are facing new and longstanding challenges. -
New IBD drug trial underway at University GI
Some patients enrolled at Providence, R.I.-based University Gastroenterology have begun to see a clinical trial of ozaminod, 10 WJAR reported Oct. 8. -
20 hospitals with the highest GI procedure volume
Cleveland Clinic has the highest gastroenterology procedure volume, according to a recent report from Definitive Healthcare. -
Baptist Health Medical Group Gastroenterology relocates
Baptist Health Medical Group Gastroenterology & Urology is relocating to a new facility in Corbin, Ky., according to an Oct. 9 report from the Times-Tribune. -
Temple Health fights boosts CRC screenings with free at-home tests
Medical students and new physicians at Philadelphia-based Temple Health are trying to close the gap in CRC screening rates with a free, at-home test kit program, ABC 6 reported Oct. 8. -
Shared decision-making in CRC screenings after 75: 10 things to know
Physician training in shared decision-making did not increase the proportion of older adults receiving their preferred CRC screening, Medscape Medical News reported Oct. 3. -
The 25 best hospitals for pediatric GI care
Cincinnati Children's has been named the top facility for pediatric gastroenterology and GI surgery in 2024 by U.S. News & World Report. -
Non-traditional CRC screening tools: 7 things to know
The FDA has recently approved two new tests for colorectal cancer screenings. These tests are less invasive, and may encourage more patients to seek care. -
GI compensation, workforce in 2024: 10 notes
Gastroenterologist compensation has continued to rise in the last several years, while burnout has declined. Here are 10 notes on the GI workforce in 2024: -
Next-generation CRC test earns FDA approval
The FDA has approved the Cologuard Plus test, a next-generation, multitarget stool DNA test approved for patients at an average risk for colorectal cancer. -
No link between antibiotics, CRC in younger patients: Study: 10 things to know
A recent study by Oakland, Calif.-based Kaiser Permanente found that antibiotics use is unlikely to be a factor in the increase in CRC diagnosis in adults under 50. -
More young patients getting colonoscopies: 7 things to know
In 2021, an advisory panel lowered the recommended age for when people should begin colon cancer screenings from 50 to 45. According to new data, there has since been a small but significant increase in screenings among younger people, according to an Oct. 3 report from CNBC. -
Interventional endoscopy leader joins NYU Langone
Nikhil Kumta, MD, a distinguished leader in the field of advanced endoscopy, has been named chief of endoscopy at Tisch Hospital and Kimmel Pavilion in New York City. -
UCLA receives grant to boost CRC screenings in underserved areas
Researchers from UCLA Health's Jonsson Comprehensive Cancer Center received a $3 million grant from the National Institutes of Health to enhance follow-up care after colorectal cancer screenings in underserved populations. -
Robotic surgery better for colorectal cancer patients: 5 things to know
A new study, published in the Journal of Robotic Surgery, shows that robotic surgery provides an advantage for patients over traditional laparoscopic approaches to colorectal resections. -
GI prescription provider renews Medicaid contract
RedHill Biopharma, a specialty biopharmaceutical company with a focus on developing treatments for the bacterial infection H. pylori, has renewed its contract with Medi-Cal, California's Medicaid healthcare program. -
Early anti-TNF treatment linked to Crohn's remission: Study
A multicenter prospective cohort study of patients with Crohn's disease found that patients who received high concentrations of anti-tumor necrosis factor therapy were linked to a greater probability of sustained remission, Medscape Medical News reported Oct. 1. -
Bariatric surgeon to pay $45K to settle false claims allegations
A physician who formerly worked at Steward Easton (Pa.) Hospital has agreed to pay $45,000 plus interest to resolve allegations that he submitted false claims to Medicaid and Medicare by improperly billing esophagogastroduodenoscopies.
Page 4 of 220